Missed Nvidia? Missed Tesla? The Marketing AI Could Win Big
A new AI-driven marketing platform is selling shares at $0.85 in a Reg A+ offering, pitched as the ChatGPT of marketi...
What Is The Best Advice For First Time Investors
First-time investors can benefit greatly from expert advice. Learn key strategies to navigate the investment landscape effectively.
28,248 articles
Why This Limited Insider Sale Matters More Than EBITDA
A seasoned investor’s eye looks beyond a single insider trade. This article breaks down why this limited insider sale...
Founder Back at Simply Good Foods as Sentiment Shifts
The founder is back at Simply Good Foods, triggering a shift in market mood as insiders buy and Reddit chatter tilts ...
QQQI Yields Almost 14%: Can It Survive a Dot-Com Recession
The NEOS Nasdaq-100 High Income ETF (QQQI) currently yields almost 14%, drawing income seekers. But can this strategy...
Iridium, Spacemobile, Redwire Lead February Moves
February highlighted a split in space stocks: Iridium rose on stabilizing results, while Redwire and Spacemobile tumb...
AI Shake: Solstice Advanced Materials Joins S&P MidCap
Solstice Advanced Materials and SiTime were added to the S&P MidCap 400 during the March 2026 quarterly rebalance, un...
Wall Street Quietly Pricing in $100 Oil, Energy Winners Emerge
ExxonMobil and Chevron are rallying as investors price in a richer oil regime, with big-cap budgets and buyback plans...
If Oil Hits $100 These Energy Dividends to Watch Right Now
As oil approaches the $100 threshold, major energy producers could boost dividends and buybacks. Here's which names c...
Klarna Today: Outperforming Other BNPL Stocks in 2026
Klarna shares jumped about 15% intraday after a solid Q1 2026 report, fueling a debate on whether Klarna today: outpe...
Bullish (BLSH) 2026 Earnings: Outlook, Drivers, and Risks
Investors are watching Bullish (BLSH) as Q1 2026 results set the tone for the year. This guide breaks down the earnin...
President Trump's Drug Pricing Policy and Pharma Stocks
Policy shifts around president trump's drug pricing could squeeze pharma profits and shift stock dynamics. This guide...
Johnson Johnson Hopes Dethrone AbbVie’s Growth Driver
Two pharma giants are wighting for a leadership position in immunology. This piece explains why Johnson Johnson hopes...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status